Cohance FDA Form 483

Indian shares set for modest gains, but Mideast tensions keep investors wary

Indian stock markets are poised for gains despite Middle East tensions influencing oil prices, while Cohance Lifesciences received FDA Form 483 observations during a plant inspection.